Scaling up liquid formulations can present a number of challenges and headaches. This is especially true for complex solutions, suspensions, and emulsions, as well as biologics, sterile products, potent compounds, and sensitive APIs. In this webcast, learn about potential formulation and filling issues when transitioning a liquid formulation from feasibility through commercialization.
Learn how to avoid common pitfalls in the transfer and scale-up process using an integrated approach, with industry experts sharing key considerations when planning for scale-up of a development program.
Pharmacokinetic and pharmacodynamic differences can make drug development for very young patients quite challenging. One can think of pediatric medicines as one of the last uncharted frontiers in patient-centric drug development. Read about the many improvements in pediatric drug development that have occurred during the last 15 years and what is being done to continue moving forward.
An efficient process from candidate selection to Phase 1 that reduces risk and offers the best chance of success is invaluable in accelerating your development path.
This website uses cookies to ensure you get the best experience on our website. Learn more
